Metal complexes with superoxide dismutase-like activity as candidates for anti-prion drug

Bioorganic & Medicinal Chemistry Letters
2006.0

Abstract

Various compounds were evaluated for ability to inhibit the formation of the abnormal protease-resistant form of prion protein (PrP-res) in two cell lines infected with different prion strains. Examination of the structure-activity relationships indicated that compounds with copper-selective chelating ability and whose copper complexes have high SOD-like activity are candidates for anti-prion drug.

Knowledge Graph

Similar Paper

Metal complexes with superoxide dismutase-like activity as candidates for anti-prion drug
Bioorganic & Medicinal Chemistry Letters 2006.0
New Series of Antiprion Compounds:  Pyrazolone Derivatives Have the Potent Activity of Inhibiting Protease-Resistant Prion Protein Accumulation
Journal of Medicinal Chemistry 2007.0
Similar Structure−Activity Relationships of Quinoline Derivatives for Antiprion and Antimalarial Effects
Journal of Medicinal Chemistry 2006.0
Structure–activity relationship study of 9-aminoacridine compounds in scrapie-infected neuroblastoma cells
Bioorganic & Medicinal Chemistry Letters 2006.0
Structure−Activity Relationship Study of Prion Inhibition by 2-Aminopyridine-3,5-dicarbonitrile-Based Compounds:  Parallel Synthesis, Bioactivity, and in Vitro Pharmacokinetics
Journal of Medicinal Chemistry 2007.0
Cupriphilic compounds to aid in proteasome inhibition
Bioorganic & Medicinal Chemistry Letters 2016.0
Design, Synthesis, and Structure−Activity Relationship of Indole-3-glyoxylamide Libraries Possessing Highly Potent Activity in a Cell Line Model of Prion Disease
Journal of Medicinal Chemistry 2009.0
Synthesis and evaluation of 8-hydroxyquinolin derivatives substituted with (benzo[d][1,2]selenazol-3(2H)-one) as effective inhibitor of metal-induced Aβ aggregation and antioxidant
Bioorganic & Medicinal Chemistry 2016.0
Antiprion activity of functionalized 9-aminoacridines related to quinacrine
Bioorganic & Medicinal Chemistry 2008.0
Synthesis and evaluation of selegiline derivatives as monoamine oxidase inhibitor, antioxidant and metal chelator against Alzheimer’s disease
Bioorganic & Medicinal Chemistry 2015.0